News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Gaston-Dreyfus Remi
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/27/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 4,997 shares
@ $0
Converted 4,997 options to buy
@ $0 |
|
| 10/28/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/28/2019 |
SC 13D/A
| Gaston-Dreyfus Remi reports a 32.8% stake in Bionik Laboratories Corp. |
| 08/28/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Bought 106,358 shares
@ $3.76, valued at
$399.9k
|
|
| 07/30/2019 |
4
| Gaston-Dreyfus Remi (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Granted 115,759 options to buy
@ $3.59, valued at
$415.6k
|
|
| 06/04/2019 |
4
| Gaston-Dreyfus Remi (Director) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Granted 5,000 options to buy
@ $3.16, valued at
$15.8k
|
|
| 04/05/2019 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 197,234 shares
@ $3.8875, valued at
$766.7k
|
|
| 08/09/2018 |
SC 13D/A
| Gaston-Dreyfus Remi reports a 36.8% stake in Bionik Laboratories Corp. |
| 07/26/2018 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 43,468,547 shares
@ $0.0513, valued at
$2.2M
|
|
| 06/28/2018 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 15,740,728 shares
@ $0.0625, valued at
$983.8k
|
|
| 06/28/2018 |
SC 13D/A
| Gaston-Dreyfus Remi reports a 34.8% stake in Bionik Laboratories Corp. |
| 05/08/2018 |
SC 13D
| Gaston-Dreyfus Remi reports a 34.1% stake in Bionik Laboratories Corp. |
| 04/03/2018 |
4
| Gaston-Dreyfus Remi (10% Owner) has filed a Form 4 on Bionik Laboratories Corp.|
Txns:
| Converted 63,197,149 shares
@ $0.0625, valued at
$3.9M
Converted 12,266,240 shares
@ $0.0625, valued at
$766.6k
Granted 1,760,704 warrants
@ $0.0625, valued at
$110k
Granted 1,600,640 warrants
@ $0.0625, valued at
$100k
Granted 5,858,343 warrants
@ $0.0625, valued at
$366.1k
|
|
| 09/11/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|